Search

Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogen small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, reported that the Company has executed a [...]

BOSTON: Revitope Oncology, Inc. has issued the following news release: Revitope Oncology Inc. (Revitope), a biotechnology company advancing a new class of precision cancer immunotherapies, announced today that it has [...]

ROCKVILLE: MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, and Kamau Therapeutics, [...]

HOLON, Israel, Aug. 29, 2024 /PRNewswire/ -- http://www.cgen.com/(Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will present virtually [...]

* Agreement leverages Sangamo's proprietary capsid delivery platform and epigenetic regulation capabilities to address certain neurodegenerative diseases * Sangamo expected to receive $50 million in near-term upfront license fees and [...]

BEIJING: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has issued the following news release: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel [...]

Reuters - AstraZeneca in $1.9 bln licensing deal with HK-listed CSPC - 7/10/2024 AstraZeneca (AZN.L), opens new tab said on Monday it would pay up to $1.92 billion to CSPC [...]

ITM Isotope Technologies Munich SE (ITM), a radiopharmaceutical biotech company and Debiopharm, a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, reported that [...]

Sangamo Therapeutics, a genomic medicine company, reported it has entered into a license agreement with Genentech, a member of the Roche Group, to develop intravenously administered genomic medicines to treat [...]

M2 PHARMA-August 2, 2024-BridGene Biosciences expands strategic collaboration and licensing agreement with Galapagos NV (C)2024 M2 COMMUNICATIONS California-based company that deals with the discovery of small molecule drugs for traditionally [...]

M2 EQUITYBITES-August 2, 2024-BridGene Biosciences expands strategic collaboration and licensing agreement with Galapagos NV (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk California-based company that deals with the discovery of small molecule drugs for [...]

M2 EQUITYBITES-August 1, 2024-Valneva licenses Shigella vaccine candidate from LimmaTech (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Vaccine companies Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and LimmaTech Biologics AG announced on Thursday a strategic [...]

M2 PHARMA-August 1, 2024-Valneva licenses Shigella vaccine candidate from LimmaTech (C)2024 M2 COMMUNICATIONS Vaccine companies Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and LimmaTech Biologics AG announced on Thursday a strategic partnership [...]

NANJING: Triastek Inc. (Triastek), a global leader in 3D printing pharmaceuticals, announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE (BioNTech), a [...]

WEST SACRAMENTO: Nufarm has issued the following news release: Yield10 Bioscience, Inc. (OTC:YTEN) ('Yield10' or the 'Company'), an agricultural bioscience company, announced that the Company has signed a Memorandum of [...]

WOBURN: Yield10 Bioscience, Inc. (OTC:YTEN) (Yield10 or the Company), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (MOU) and License Agreement with Nuseed [...]

WEST SACRAMENTO: Yield10 Bioscience, Inc. announced that the Company has signed a Memorandum of Understanding and License Agreement with Nuseed Nutritional US Inc. granting Nufarm a commercial license to certain [...]

(GlobeNewswire) - Yield10 Bioscience, Inc. (OTC:YTEN) (Yield10 or the Company), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (MOU) and License Agreement with [...]

(GlobeNewswire) - Yield10 Bioscience, Inc. (OTC:YTEN) (Yield10 or the Company), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (MOU) and License Agreement with [...]

(GLOBE NEWSWIRE via COMTEX) -- WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) ('Yield10' or the 'Company'), an agricultural bioscience company, today announced that the [...]

WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) ('Yield10' or the 'Company'), an agricultural bioscience company, today announced that the Company has signed a Memorandum [...]

- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10's assets to Nufarm WOBURN, Mass. [...]

PARIS: Ipsen announced confirmation of an expanded collaboration and license agreement with Exelixis, Inc. for the development of Cabometyx(r) (cabozantinib) in advanced pancreatic neuroendocrine tumors (pNETs) and advanced extra-pancreatic neuroendocrine [...]

PISCATAWAY: KASHIV BIOSCIENCES, LLC has issued the following news release: Kashiv BioSciences, LLC ('Kashiv' or the 'Company') today announced that it has entered into an exclusive licensing agreement for ADL018, [...]

EL CAJON: PURE Bioscience, Inc. and AgroVet Alliance, FZE enter into a multi-year international supply and license agreement for the purchase and selling of SDC products under special terms and [...]

EL CAJON, Calif. -- PURE Bioscience, Inc. (OTCQB: PURE) ('PURE,' the 'Company' or 'we'), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and AgroVet Alliance, FZE ('AVA'), have [...]

CAMBRIDGE: Nona Biosciences has issued the following news release: Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to ITM), ranging from target validation [...]

London: MaxCyte Inc has issued the following press release: MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies developing 'next-generation cell therapeutics' - Inks strategic platform license agreement [...]

CAMBRIDGE, Mass., May 22, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to I[sup.TM]), ranging from target validation and antibody [...]

ALAMEDA: Exelixis, Inc. (Nasdaq: EXEL) announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla). This settlement resolves two [...]

ALAMEDA, Calif. -- Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla). This [...]

GAITHERSBURG, Md. -- The following information was released by Novavax, Inc.: Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 [...]

Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards Provides Novavax with cash and an equity investment totalling approximately [...]

(GLOBE NEWSWIRE via COMTEX) -- Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines - Agreement provides patients with broader access to [...]